Answers are grounded in this paper and cite their sources.
The synthesis of stable 1,3-bis(N,N-dialkylamino)imidazolin-2-ylidenes was accomplished from readily available chiral bis-hydrazones after reduction or addition of PhMgCl, cyclization to imidazolinium salts, and treatment with KN(SiMe3)2. This strategy allows the obtention of free imidazolin-2-ylidenes and their Rh(COD)Cl complexes in enantiomerically pure form. The sigma-donor ability of dialkylamino-substituted diaminocarbenes was found to be slightly higher than that of alkyl(aryl) analogues.
No takes yet. Share an insight, caveat, or question.
Alcarazo et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: